Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group
  2. Taxonomy
  3. Term
  4. Other

Intravitreal Anti-VEGF Therapy for Advanced Ocular Disease of Von Hippel-Lindau Disease

Go back to Resources

Intravitreal Anti-VEGF Therapy for Advanced Ocular Disease of Von Hippel-Lindau Disease

Authors:

Location:

Go back to Resources

Late Breaking Results of the First International Multicenter Trial of Islet Transplantation in Type 1 Diabetes with the Edmonton Protocol

Go back to Resources

Late Breaking Results of the First International Multicenter Trial of Islet Transplantation in Type 1 Diabetes with the Edmonton Protocol

Authors:

Location:

Go back to Resources

NIH-Supported National Islet Transplantation Registry

Go back to Resources

NIH-Supported National Islet Transplantation Registry

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

NIH-supported national transplant registry

Go back to Resources

NIH-supported national transplant registry

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Ocular risk factors for developing Neovascular AMD in the fellow eyes of patients with unilateral Neovascular AMD

Go back to Resources

Ocular risk factors for developing Neovascular AMD in the fellow eyes of patients with unilateral Neovascular AMD

Authors:

Location:

Go back to Resources

Pediatric transplantation of the kidney, liver and heart: Summary report

Go back to Resources

Pediatric transplantation of the kidney, liver and heart: Summary report

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Phase II Trial of Celebrex in Photodynamic Therapy (C-PDT) for Neovascular Age-related Macular Degeneration (AMD): Rationale and Baseline Characteristics

Go back to Resources

Phase II Trial of Celebrex in Photodynamic Therapy (C-PDT) for Neovascular Age-related Macular Degeneration (AMD): Rationale and Baseline Characteristics

Authors:

Location:

Go back to Resources

Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine

Go back to Resources

Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

(Collaborative Islet Transplant Registry [CITR])

Go back to Resources

(Collaborative Islet Transplant Registry [CITR])

Authors:

Secondary:

Volume:

Go back to Resources

A prospective, randomized, trial of the effect of multi-center trial of antibody induction in simultaneous pancreas and kidney transplantation: three year results

Go back to Resources

A prospective, randomized, trial of the effect of multi-center trial of antibody induction in simultaneous pancreas and kidney transplantation: three year results

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Pagination

  • Previous page ‹‹
  • Page 143
  • Next page ››
Subscribe to Other
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification